Wall Street Experts
ver. ZuMIgo(08/25)
Cullinan Oncology, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -187
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
Rok finansowy |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
19 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
inf% |
-100.0% |
0.0% |
0.0% |
Marża brutto |
0.0% |
-inf% |
-inf% |
99.7% |
-inf% |
-inf% |
-inf% |
EBIT (mln) |
-15 |
-22 |
-60 |
-68 |
145 |
-191 |
-197 |
EBIT Δ r/r |
0.0% |
52.7% |
170.9% |
12.6% |
-312.9% |
-231.8% |
3.3% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
-358.7% |
0.0% |
0.0% |
nan |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
-562 |
0 |
0 |
EBITDA (mln) |
-15 |
-22 |
-60 |
-68 |
-409 |
-190 |
-167 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
-358.7% |
0.0% |
0.0% |
nan |
Podatek (mln) |
0 |
-2 |
-9 |
-2 |
42 |
-14 |
0 |
Zysk Netto (mln) |
-14 |
-20 |
-51 |
-65 |
111 |
-153 |
-167 |
Zysk netto Δ r/r |
0.0% |
41.2% |
153.8% |
27.9% |
-271.0% |
-237.7% |
9.3% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
-343.3% |
0.0% |
0.0% |
nan |
EPS |
-1.24 |
-0.46 |
-1.17 |
-1.47 |
2.46 |
-3.69 |
-3.11 |
EPS (rozwodnione) |
-1.24 |
-0.46 |
-1.17 |
-1.47 |
2.38 |
-3.69 |
-3.11 |
Ilośc akcji (mln) |
11 |
44 |
44 |
44 |
45 |
42 |
54 |
Ważona ilośc akcji (mln) |
11 |
44 |
44 |
44 |
47 |
42 |
54 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |